Ozempic can even cut the risk of Alzheimer’s disease, study says
Novo Nordisk’s blockbuster drug Ozempic (NVO) is linked to yet another health benefit. This time it’s lowering the risk of ...
Pulse59m
MHRA urges GPs to be alert to signs of GLP-1 agonist ‘misuse’
The medicines regulator has urged GPs to be alert to signs of ‘misuse’ of GLP-1 receptor agonists for weight loss, such as ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
JD Supra12m
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List
Less than a week after the U.S. Food & Drug Administration (FDA) determined that the shortage of the tirzepatide injection, a glucagon-like peptide ...
Viking Therapeutics jumps as obesity updates outshine Q3 beat
Viking Therapeutics (NASDAQ:VKTX) added ~18% on Thursday to reach a five-month high as Wall Street focused on updates on its ...